Cambridge Investment Research Advisors’s Fidelity Enhanced Large Cap Value ETF FELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55M Buy
138,347
+33,409
+32% +$1.28M 0.01% 983
2026
Q1
$3.66M Buy
104,938
+7,596
+8% +$272K 0.01% 1155
2025
Q4
$3.37M Sell
97,342
-9,302
-9% -$316K 0.01% 1151
2025
Q3
$3.58M Sell
106,644
-436
-0.4% -$14.2K 0.01% 1104
2025
Q2
$3.4M Buy
107,080
+6,206
+6% +$188K 0.01% 1074
2025
Q1
$3.1M Buy
100,874
+13,481
+15% +$421K 0.01% 1069
2024
Q4
$2.66M Buy
87,393
+13,785
+19% +$434K 0.01% 1163
2024
Q3
$2.28M Buy
73,608
+24,386
+50% +$724K 0.01% 1249
2024
Q2
$1.41M Sell
49,222
-5,810
-11% -$165K 0.01% 1536
2024
Q1
$1.61M Buy
55,032
+1,049
+2% +$28.9K 0.01% 1403
2023
Q4
$1.45M Buy
+53,983
New +$1.4M 0.01% 1414

Other funds holding FELV

Cambridge Investment Research Advisors's FELV Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Fidelity Enhanced Large Cap Value ETF (FELV) stake by 32% in Q2 2026, buying an estimated $1.28M and bringing the position to 138,347 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #983.

Cambridge Investment Research Advisors first reported a position in FELV in Q4 2023 and has held it in 11 quarters since. 185 funds tracked by Wall St. Rank hold FELV as of Q2 2026.

  • Cambridge Investment Research Advisors held 138,347 shares of Fidelity Enhanced Large Cap Value ETF worth $5.55M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 33,409 Fidelity Enhanced Large Cap Value ETF shares in Q2 2026, an estimated $1.28M.
  • Fidelity Enhanced Large Cap Value ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #983 holding.
  • Cambridge Investment Research Advisors first reported a position in Fidelity Enhanced Large Cap Value ETF in Q4 2023 and has held it in 11 quarters since.
  • 185 funds tracked by Wall St. Rank held Fidelity Enhanced Large Cap Value ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.